ArticleScientific reports2025
Sonochemically enhanced activated charcoal with improved oral palatability for efficient in vitro detoxification of acetaminophen.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Core-shell alginate-sulfonic acid networks crosslinked by multivalent cations (CaRSC advances · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Acetaminophen (APAP) overdose is a major cause of drug-induced liver injury, underscoring the urgent need for detoxification agents that are both effective and suitable for oral administration. In this study, we developed a novel activated charcoal (UA-AChar) derived from Calligonum comosum wood, employing ammonium chloride-assisted chemical activation combined with ultrasonic treatment. The resulting material demonstrated an exceptionally high specific surface area (1531 m²/g), a mesoporous structure with a pore size of 2.20 nm, and a rich functional group composition containing both oxygen and nitrogen, all of which significantly enhance its adsorption performance. UA-AChar demonstrated high adsorption efficiency, achieving 89% and 86% removal of APAP within 15 min at pH 1.2 and 7.5, respectively, with a dosage of 0.4 g/L and an initial APAP concentration of 50 mg/L. In equilibrium studies at higher concentrations (500 mg/L), the maximum adsorption capacities reached 787.5 mg/g at pH 1.2 and 725 mg/g at pH 7.5. The experimental data were best described by the Freundlich isotherm, indicating multilayer adsorption on heterogeneous surfaces. Kinetic analysis revealed that the adsorption process followed a pseudo-second-order model. UA-AChar was incorporated into yogurt, ice cream, and honey to improve its oral acceptability. The addition of these flavoring agents preserved the adsorption efficiency within a clinically acceptable range (≤ 7% reduction), underscoring their potential to enhance palatability. Consequently, UA-AChar presents a promising and effective solution for managing APAP overdose, offering a patient-friendly approach to oral detoxification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.